English
Natalizumab Biosimilar - Research Grade: Dylight®488
Natalizumab Biosimilar - Research Grade: Dylight®488, Host: CHO Cells, Human IgG4-Kappa
Artikelnummer
ICH4037D488-100UG
Verpackungseinheit
100μg
Hersteller
Ichorbio
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Target: CD49d.
Concentration: 0.2mg/ml.
Formulation: This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Concentration: 0.2mg/ml.
Formulation: This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
| Artikelnummer | ICH4037D488-100UG |
|---|---|
| Hersteller | Ichorbio |
| Hersteller Artikelnummer | ICH4037D488-100UG |
| Verpackungseinheit | 100μg |
| Mengeneinheit | STK |
| Reaktivität | Human |
| Methode | Flow Cytometry, Immunohistochemistry |
| Isotyp | Human IgG4-Kappa |
| Wirt | Cell Line |
| Produktinformation (PDF) | Download |
| MSDS (PDF) | Download |
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
